Plain-English translation of NCT06941389 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The WeDecide study is comparing two main ways to treat sickle cell disease in children: stem cell transplantation from a matched family donor, and non-transplant medicines that help manage the disease. Researchers want to understand how each approach affects children's quality of life, brain function, and long-term health over three years.
Doctors have several treatment options for children with sickle cell disease, but there hasn't been a large study directly comparing how well they work and how they affect children's everyday lives. This research will help families and doctors choose the best treatment path for each child.
You likely qualify if…
You likely don't qualify if…
If you join the stem cell transplant group, you'll have health assessments before your transplant and then at several points afterward. If you join the medicine group, you'll have assessments when you start and then once a year for three years. Both groups will answer questions about how you're feeling, take some simple tests, and share information about your hospital visits and overall health.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States